The COVID-19 pandemic made the world realize the importance of investing in healthcare infrastructure and developing treatments for unmet ...

While additional drugs in the same class are sure to earn FDA approval in the coming years, Eli Lilly is well positioned in ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, both of whom expressed interest in supporting the activist investor's ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

The plaintiffs allege that the shortage of Lilly’s drugs isn’t actually over, and that the agency’s decision deprives ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.